New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
10:09 EDTDHI, D, ANR, UNM, NVS, IBM, COST, N, VZ, SRC, MIDD, HMC, ALU, LVS, WLT, KEY, STR, KBHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Alcatel-Lucent (ALU) upgraded to Neutral from Sell at Citigroup... Costco (COST) upgraded to Market Perform from Underperform at Bernstein... D.R. Horton (DHI) upgraded to Market Perform from Underperform at Raymond James... Honda (HMC) upgraded to Outperform from Neutral at Macquarie... IBM (IBM) upgraded to Hold from Sell at Societe Generale... KB Home (KBH) upgraded to Market Perform from Underperform at Raymond James... Middleby (MIDD) upgraded to Outperform from Neutral at RW Baird.. Novartis (NVS) upgraded to Buy from Neutral at Citigroup... Platinum Group (PLG) upgraded to Outperform from Sector Perform at RBC Capital... Questar (STR) upgraded to Buy from Neutral at Citigroup... Spirit Realty (SRC) upgraded to Outperform from Market Perform at Raymond James... Unum Group (UNM) upgraded to Overweight from Equal Weight at Barclays... Verizon (VZ) upgraded to Buy from Hold at Canaccord... KeyCorp (KEY) upgraded to Outperform from Sell at CLSA... Alpha Natural (ANR) upgraded to Buy from Hold at Dahlman Rose... Walter Energy (WLT) upgraded to Buy from Hold at Dahlman Rose... NetSuite (N) upgraded to Buy from Neutral at Lazard Capital... Disney (D) upgraded to Buy from Neutral at B. Riley Caris... Las Vegas Sands (LVS) upgraded to Neutral from Sell at Compass Point.
News For ALU;COST;DHI;HMC;IBM;KBH;MIDD;NVS;STR;SRC;UNM;KEY;VZ;ANR;WLT;N;D;LVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
March 17, 2015
16:13 EDTHMCHonda Aero receives FAA production certificate for HF120 Turbofan jet engine
Subscribe for More Information
12:51 EDTNVSNovartis hit with $100M gender discrimination lawsuit, Reuters reports
A proposed class action lawsuit against Novartis claims the drug maker routinely denied female employees equal pay and promotional opportunities, reports Reuters. The $110M lawsuit filed on Tuesday says Novartis' Alcon Laboratories maintains a "boy's club atmosphere" that is hostile to women and bars them from leadership positions. Reference Link
12:05 EDTANRU.S. coal sector predicted to see 'wave of bankruptcies'
Subscribe for More Information
10:00 EDTNOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aimco (AIV) initiated with an Outperform at RW Baird... Alnylam (ALNY) initiated with a Buy at Janney Capital... American Campus (ACC) initiated with a Neutral at RW Baird... AvalonBay (AVB) initiated with a Neutral at RW Baird... BE Aerospace (BEAV) initiated with a Buy at CRT Capital... BlackRock (BLK) initiated with a Buy at Argus... Camden Property (CPT) initiated with an Outperform at RW Baird... CarMax (KMX) initiated with a Buy at Evercore ISI... Central Pacific (CPF) initiated with a Neutral at Macquarie... Cognex (CGNX) initiated with a Buy at Northcoast... Education Realty (EDR) initiated with a Neutral at RW Baird... EnerSys (ENS) initiated with an Overweight at Stephens... Equity Lifestyle (ELS) initiated with an Outperform at RW Baird... Equity Residential (EQR) initiated with a Neutral at RW Baird... Essex Property Trust (ESS) initiated with a Neutral at RW Baird... Facebook (FB) initiated with a Buy at Brean Capital... Intercept (ICPT) initiated with a Hold at MLV & Co.... Isis Pharmaceuticals (ISIS) initiated with a Neutral at Janney Capital... LinkedIn (LNKD) initiated with a Sell at Brean Capital... Mid-America Apartment (MAA) initiated with an Outperform at RW Baird... NetSuite (N) initiated with a Hold at Brean Capital... Paycom (PAYC) initiated with a Buy at Brean Capital... Platform Specialty Products (PAH) initiated with a Buy at UBS... Post Properties (PPS) initiated with a Neutral at RW Baird... Salesforce.com (CRM) initiated with a Hold at Brean Capital... ServiceNow (NOW) initiated with a Buy at Brean Capital... Snap-On (SNA) initiated with a Buy at Northcoast... Sun Communities (SUI) initiated with a Neutral at RW Baird... Twitter (TWTR) initiated with a Buy at Brean Capital... UDR, Inc. (UDR) initiated with an Outperform at RW Baird... Workday (WDAY) initiated with a Hold at Brean Capital... Xplore Technologies (XPLR) initiated with a Buy at Roth Capital... Yahoo (YHOO) initiated with a Hold at Argus.
07:12 EDTIBMDeutsche Messe to hold a conference
CeBIT 2015 is being held in Hannover, Germany on March 15-20.
06:26 EDTCOSTCostco temporarily barred from importing fish into Canada, WSJ says
Subscribe for More Information
06:10 EDTVZSpherix announces Markman hearing held as scheduled in Verizon case
Subscribe for More Information
05:32 EDTNVSIncyte announces Novartis receives EC approval for Jakavi
Incyte (INCY) announced that Novartis (NVS) received approval from the European Commission for Jakavi for the treatment of adult patients with polycythemia vera, or PV, who are resistant to or intolerant of hydroxyurea. Jakavi is the first targeted treatment approved by the European Commission for these patients. Under the Incyte-Novartis Collaboration and License Agreement signed in 2009, Novartis received exclusive development and commercialization rights to ruxolitinib outside of the United States for all hematologic and oncologic indications, and sells ruxolitinib under the name Jakavi. Ruxolitinib is marketed by Incyte in the United States as Jakafi. Jakafi is approved by the FDA for treatment of people with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. Jakafi is also indicated for treatment of people with intermediate or high-risk myelofibrosis, or MF, including primary MF, post–polycythemia vera MF, and post–essential thrombocythemia MF.
05:30 EDTNVSNovartis receives EU approval for Jakavi in polycythemia vera
Novartis announced that the European Commission has approved Jakavi for the treatment of adult patients with polycythemia vera, or PV, who are resistant to or intolerant of hydroxyurea. Jakavi is the first targeted treatment approved by the European Commission for these patients. Jakavi is the only JAK 1/2 inhibitor available to treat PV and is also currently approved in more than 80 countries to treat myelofibrosis.
March 16, 2015
16:37 EDTNNetSuite initiated with a Hold at Brean Capital
Subscribe for More Information
12:56 EDTIBMIBM protest of Army contract an incremental negative for CACI, says Maxim
According to a Washington Technology article, IBM (IBM) successfully protested a $158M Army-payroll contract awarded to CACI (CACI). Maxim expects the contract to be re-evaluated and for CACI to still prevail and win, but the revenue ramp will take longer than previously anticipated. The firm rates CACI a Buy with a $101 price target.
12:54 EDTIBMContract awarded to CACI protested by IBM, Washington Technology reports
A $158M Army payroll and personnel contract that was awarded to CACI (CACI) has been successfully protested by IBM (IBM) and the contract has been dismissed, Washington Technology reports. Reference Link
11:50 EDTANRAlpha Natural affiliate miner suffers fatal injury at Deep Mine 41 in Virginia
Subscribe for More Information
09:37 EDTLVSActive equity options trading on open
Subscribe for More Information
March 15, 2015
16:14 EDTIBMBlackBerry collaborates with IBM, Samsung on SecuTABLET
Subscribe for More Information
March 13, 2015
15:19 EDTKBHKB Home March volatility elevated into Q1 and outlook
Subscribe for More Information
09:29 EDTIBMIBM to hold a meeting with a conference call hookup
Management discusses IBM Mainframe z13 in a meeting being held in Armonk, New York on March 13 at 2 pm. Webcast Link
09:20 EDTVZBofA/Merrill media/telecom analysts hold analyst/industry conference call
Media & Telecom Analyst Reif-Cohen and Barden, along with Matthew Brill, Pratner at Latham & Watkins LLP, discuss the FCC Open Internet Order on an Analyst/Industry conference call to be held on March 13 at 11 am.
06:55 EDTIBMIBM considering using bitcoin tech for major currencies, Reuters says
Subscribe for More Information
05:40 EDTNVSNovartis to present Cosentyx data at AAD 2015
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use